Improved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound.

TitleImproved cancer risk stratification of isoechoic thyroid nodules to reduce unnecessary biopsies using quantitative ultrasound.
Publication TypeJournal Article
Year of Publication2024
AuthorsGoundan PN, Lye T, Markel A, Mamou J, Lee SL
JournalFront Endocrinol (Lausanne)
Volume15
Pagination1326188
Date Published2024
ISSN1664-2392
KeywordsBiopsy, Fine-Needle, Humans, Retrospective Studies, Risk Assessment, Thyroid Neoplasms, Thyroid Nodule, United States
Abstract

OBJECTIVE: Gray-scale ultrasound (US) is the standard-of-care for evaluating thyroid nodules (TNs). However, the performance is better for the identification of hypoechoic malignant TNs (such as classic papillary thyroid cancer) than isoechoic malignant TNs. Quantitative ultrasound (QUS) utilizes information from raw ultrasonic radiofrequency (RF) echo signal to assess properties of tissue microarchitecture. The purpose of this study is to determine if QUS can improve the cancer risk stratification of isoechoic TNs.

METHODS: Patients scheduled for TN fine needle biopsy (FNB) were recruited from the Thyroid Health Clinic at Boston Medical Center. B-mode US and RF data (to generate QUS parameters) were collected in 274 TNs (163 isoechoic, 111 hypoechoic). A linear combination of QUS parameters (CQP) was trained and tested for isoechoic [CQP(i)] and hypoechoic [CQP(h)] TNs separately and compared with the performance of conventional B-mode US risk stratification systems.

RESULTS: CQP(i) produced an ROC AUC value of 0.937+/- 0.043 compared to a value of 0.717 +/- 0.145 (p >0.05) for the American College of Radiology Thyroid Imaging, Reporting and Data System (ACR TI-RADS) and 0.589 +/- 0.173 (p >0.05) for the American Thyroid Association (ATA) risk stratification system. In this study, CQP(i) avoids unnecessary FNBs in 73% of TNs compared to 55.8% and 11.8% when using ACR TI-RADS and ATA classification system.

CONCLUSION: This data supports that a unique QUS-based classifier may be superior to conventional US stratification systems to evaluate isoechoic TNs for cancer and should be explored further in larger studies.

DOI10.3389/fendo.2024.1326188
Alternate JournalFront Endocrinol (Lausanne)
PubMed ID38370358
PubMed Central IDPMC10869503
Grant ListR21 CA212744 / CA / NCI NIH HHS / United States
Related Institute: 
Biomedical Ultrasound Research Laboratory (BURL)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065